2020 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Anticoagulant therapy during the acute phase of non-ST elevation acute coronary syndromes (NSTE-ACS) is strongly recommended by current international guidelines. Evidence supporting the use of anticoagulant therapy in the early phase of NSTE-ACS however, is based on dated trials mostly performed in the nineties and recent randomised clinical...
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Despite the increasing use of early invasive strategies in non-ST-elevation acute coronary syndromes (NSTE-ACS), optimal initial antithrombotic therapy (ATT) based on the safety/efficacy profile of all guideline-recommended combinations remains crucial for the early management of both medically and invasively treated NSTE-ACS patients.
Uploaded on: April 14, 2023 -
2020 (v1)Publication
To provide an updated assessment of the efficacy-safety profile of very short (1 or 3 months) dual antiplatelet therapy (DAPT) compared to long (12 months) DAPT in patients undergoing percutaneous coronary interventions (PCI).
Uploaded on: April 14, 2023